Follow on Google News News By Tag Industry News * Therapy * More Industries... News By Place Country(s) Industry News
Follow on Google News | Schizophrenia Therapeutics Market to Decline with 3.7% by 2017Piribo, the online destination for Pharma intelligence, has added a new report.
By: Joe Walsh The 50 page report estimated the global Schizophrenia market to be worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during 2011 to 2014. The therapeutic market for Schizophrenia declines form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014 launch of few first in class molecules is expected which is likely to lower the impact of patent expiry. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore a low treatment seeking rate and low patient compliance rate will act as a barrier to market growth. The report “Schizophrenia - Pipeline Assessment and Market Forecast to 2017” is available from Piribo at: http://www.piribo.com/ Piribo product ID: GDA00770 About Piribo Piribo http://www.piribo.com/ # # # About Piribo. Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. End
|
|